Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2565-2569

  Sobottka, Ingo ^a,d   Wegscheider, Karl ^a   Balzer, Ludwig ^a   Böger, Rainer H ^a   Hallier, Olaf ^b   Giersdorf, Ina ^c   Streichert, Thomas ^a   Haddad, Munif ^a   Platzer, Ursula ^a   Cachovan, Georg ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Maxillofacial Surgery   (Germany)

^c Emergency Hospital Berlin   (Germany)

^d LADR GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G;

ANAEROBE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HEMOLYTIC STREPTOCOCCUS; HUMAN; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; NEISSERIA; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS MITIS; TOOTH ABSCESS; TOOTH INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CLINDAMYCIN; CULTURE MEDIA; DOUBLE-BLIND METHOD; FEMALE; GERMANY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OUTPATIENTS; PENICILLINS; PERIODONTAL ABSCESS; PROSPECTIVE STUDIES; QUINOLINES;

EID: 84860181220     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06428-11     Document Type: Article

References (22)

1. Al-Nawas B, Maeurer M. 2008. Severe versus local odontogenic bacterial infections: comparison of microbial isolates. Eur. Surg. Res. 40:220-224. (Pubitemid 351252931)
2. Bascones Martínez A, et al. 2004. Consensus statement on antimicrobial treatment of odontogenic bacterial infections. Med. Oral Patol. Oral Cir. Bucal 9:363-376. (Pubitemid 40516508)
3. Cachovan G, et al. 2011. Comparative efficacy and safety of moxifloxacin versus clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob. Agents Chemother. 55:1142-1147.
4. Cachovan G, et al. 2009. Penetration of moxifloxacin into rat mandibular bone and soft tissue. Acta Odontol. Scand. 67:182-186.
5. Diz Dios P, et al. 2006. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions. Antimicrob. Agents Chemother. 50:2996-3002. (Pubitemid 44396404)
6. European Committee on Antimicrobial Susceptibility Testing (EUCAST). January 2011. Breakpoint tables for interpretation of MICs and zone diameters, version 1.3. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk- test-documents/EUCAST-breakpoints-v1.3.xls.
7. European Committee on Antimicrobial Susceptibility Testing (EUCAST). December 2010.EUCASTrecommended strains for internal quality control, version 1.3. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk-test- documents/EUCAST-QC-tables-1.3.pdf.
8. Facklam R. 2002. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15:613-630. (Pubitemid 41184081)
9. Jin WY, et al. 2011. Evaluation of VITEK 2, MicroScan, and Phoenix for identification of clinical isolates and reference strains. Diagn. Microbiol. Infect. Dis. 70:442-447.
10. Kuriyama T, et al. 2000. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90:600-608.
11. Lewis MA, et al. 1995. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J. Antimicrob. Chemother. 35:785-791.
12. Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ. 1989. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. Arch. Intern. Med. 149:2269-2273. (Pubitemid 19258172)
13. Pickerill KE, Paladino JA, Schentag JJ. 2000. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy 20:417-428. (Pubitemid 30198848)
14. Piesold JU, Al-Nawas B, Otten JE, Grötz KA. February 2008, revision date. Guidelines of the DGMKG (German Society for Oral and Craniomaxillofacial Surgery). Odontogenic infections and abscesses. AWMF (Association of the Scientific Medical Societies in Germany) science-based guidelines for diagnostics and therapy. AWMF guideline registry no. 007/006. http://www.awmf.org/leitlinien/detail/ll/007-006.html. (In German.)
15. Robertson D, Smith AJ. 2009. The microbiology of the acute dental abscess. J. Med. Microbiol. 58:155-162.
16. Sánchez R, Mirada E, Arias J, Paño JR, Burgueño M. 1 August 2011. Severe odontogenic infections: epidemiological, microbiological and therapeutic factors. Med. Oral Patol. Oral Cir. Bucal 16:e670-e676. http://www.medicinaoral.com/pubmed/medoralv16-i5-p670.pdf.
17. Schaumann R, et al. 2000. In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. Int. J. Antimicrob. Agents 16:225-232.
18. Siqueira JF, Jr, Rôças IN. 2009. The microbiota of acute apical abscesses. J. Dent. Res. 88:61-65.
19. Sobottka I, et al. 4 May 2011. Microbiological analysis of a prospective, randomised, double-blind trial comparing moxifloxacin and clindamycin in the treatment of infiltrates and abscesses, abstr. R2722. Clin. Microbiol. Infect. 17(Suppl. s4):S820. http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2011. 03559.x/pdf.
20. Sobottka I, et al. 2002. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob. Agents Chemother. 46:4019-4021. (Pubitemid 35403289)
21. Warnke PH, et al. 2008. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses. J. Craniomaxillofac. Surg. 36:462-467.
22. World Health Organization. 2010. International statistical classification of diseases and related health problems, 10th revision. http://apps.who.int/ classifications/icd10/browse/2010/en. World Health Organization, Geneva, Switzerland.